TRX2 is researching a completely novel technology that will be used as a treatment for Androgenetic Alopecia (AGA) and other hair growth disorders. We have filed and/or secured intellectual property in several dissipative areas.
We are currently conducting studies in the following independent research paths:
1) Hair restoration and re-growth,
2) The prevention of hair loss,
3) A cure against male and female pattern hair loss.
Patent applications are generally published 18 months after the earliest priority date of the application. However, because we are still in the process of securing our IP, we are not able to disclose any details that concern our research or our strategy for IP protection. This is a non-negotiable legal matter.